Details for New Drug Application (NDA): 205055
✉ Email this page to a colleague
The generic ingredient in NATEGLINIDE is nateglinide. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nateglinide profile page.
Summary for 205055
Tradename: | NATEGLINIDE |
Applicant: | Alvogen |
Ingredient: | nateglinide |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
Approval Date: | Dec 11, 2015 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 120MG | ||||
Approval Date: | Dec 11, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription